Partners CancerCare

Partners CancerCare is the integrated oncology program of Mass General Brigham, representing a premier clinical and research collaboration between Massachusetts General Hospital and Brigham and Women's Hospital. Working in close coordination with the Dana-Farber Cancer Institute, the network provides comprehensive cancer services including advanced diagnostics, precision medicine, and complex surgical interventions. As a global leader in oncology research, it hosts a vast portfolio of clinical trials spanning all phases of drug development, from first-in-human studies to large-scale Phase 3 trials. Patients benefit from a multidisciplinary care model that integrates the expertise of Harvard Medical School-affiliated faculty and researchers. The organization is dedicated to translating laboratory breakthroughs into standard-of-care treatments, utilizing world-class facilities for proton therapy, bone marrow transplantation, and cellular immunotherapy.